LEP and Insulin resistance: The progression to a more advanced EC clinical stage in patients with SO (Table 2) might be promoted by higher proportions of total and visceral body fat content, severe insulin resistance, higher serum leptin/adiponectin ratio and probably the mild prevalence of estrogenemia but not testosteronemia as compared with patients with MHO (Tables 1–3 & Figure 1).